1. Will other drugmakers end up with deals like Endo’s $10M opioid settlement? — AstraZeneca Imfinzi combo fails advanced lung cancer study — FDA says they were “lucky” with Novartis data manipulation controversy — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. What happened a year ago this week in biopharma? Regeneron’s Eylea approval, Novartis’ new ethics czar, Vertex’s Kalydeco, and Opidvo’s SCLC approval click to review and read a current update of the big stories from one year ago
    Dismiss Notice

Kimberly-Clark

Anonymous board for Kimberly-Clark

Sort By:
Title
Replies Views
Last Message ↓
  1. Anonymous
    Replies:
    13
    Views:
    4,108
  2. Anonymous
    Replies:
    5
    Views:
    6,498
  3. anonymous
    Replies:
    4
    Views:
    2,965
  4. Anonymous
    Replies:
    0
    Views:
    2,670
  5. Anonymous
    Replies:
    0
    Views:
    1,506
  6. Anonymous
    Replies:
    64
    Views:
    34,595
  7. Anonymous
    Replies:
    0
    Views:
    1,802
  8. Anonymous
    Replies:
    33
    Views:
    11,730
  9. Anonymous
    Replies:
    2
    Views:
    3,956
  10. Anonymous
    Replies:
    36
    Views:
    21,268
  11. Anonymous
    Replies:
    1
    Views:
    3,019
  12. Anonymous
    Replies:
    19
    Views:
    6,934
  13. Anonymous
    Replies:
    2
    Views:
    2,173
  14. Anonymous
    Replies:
    43
    Views:
    10,267
  15. Anonymous
    Replies:
    5
    Views:
    2,924
  16. Anonymous
    Replies:
    171
    Views:
    47,597
  17. Anonymous
    Replies:
    25
    Views:
    14,029
  18. Anonymous
    Replies:
    67
    Views:
    21,641
  19. Anonymous
    Replies:
    8
    Views:
    4,908
  20. Anonymous
    Replies:
    13
    Views:
    6,215

Thread Display Options

Loading...